OXiGENE Announces Issuance of U.S. Patent for OXi4503 in Acute Myeloid Leukemia
May 26, 2015 at 16:05 PM EDT
OXiGENE, Inc. (Nasdaq: OXGN), a biopharmaceutical company developing novel therapies for the treatment of cancer, today announced that ...